Ocular

Ocular is a biopharmaceutical company that researches and develops drugs for the treatment of ocular diseases.

Business Model:

Revenue: $49.7M

Employees: 201-500

Detailed Ocular Information

Geographic Data

Ocular headquarters map

Address: 24 Crosby Drive

City: Bedford

State: MA

Zip: 01730

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$45M

Raised Total:

$189M

Metrics

275,991Website Global Rank

240,748Website Monthly Traffic

Twitter Followers

Description

Ocular is a biopharmaceutical company that researches and develops drugs for the treatment of ocular diseases.

Contact Phone:
+17813574000

Contact Email:

Ocular went public on 7/28/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/28/2014

Ticker Symbol:
OCUL

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2019 Post-IPO Debt $37.5M
2/2007 Series A $995.8k
6/2009 Series C 3 $15M Polaris Partners
Versant Ventures
SV Health Investors
Polaris Partners
2/2019 Post-IPO Debt $37.5M Incept, LLC
5/2013 Series E $8.5M Ascension Health Ventures
7/2014 IPO $65M
1/2013 Series D $9.8M Polaris Ventures
SV Life Sciences
Versant Ventures
Ascension Health Ventures
Sparta LLC
2/2011 Series D 4 $14M Polaris Partners
Versant Ventures
Ascension Ventures
SV Health Investors
Ascension Ventures
Polaris Partners
Versant Ventures
Ascension Ventures
SV Health Investors
Ascension Ventures
12/2018 Post-IPO Debt $25M MidCap Financial
Silicon Valley Bank
1/2011 Series C 3 $6M Versant Ventures
SV Health Investors
Polaris Partners
6/2013 Series D 6 $23.8M Baxter International
Ascension Ventures
Dan Burgess
Polaris Venture Capital
Sparta Group
Versant Ventures
Sparta Group
Dan Burgess
Versant Ventures
Ascension Ventures
Polaris Venture Capital
Baxter International
Ascension Ventures
6/2015 Post-IPO Equity $88M
5/2020 Post-IPO Equity $45M
3/2008 Series B 2 $6M Versant Ventures
SV Health Investors
1/2018 Post-IPO Equity $35.1M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research